Steven Cohen Intellia Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $11 Million - $29.2 Million	-180,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $1.63 Million - $2.92 Million	34,900 Added 23.99%	180,400 $14.5 Million
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $9.56 Million - $32.2 Million	-507,619 Reduced 77.72%	145,500 $7.92 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $3.8 Million - $5.43 Million	-217,788 Reduced 25.01%	653,119 $13 Million
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $9.7 Million - $19.9 Million	870,907 New	870,907 $18.3 Million

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $997M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.